Clinical Trials
457 trialsNCT07395804 2026-05-26
23146
Bayer
Recruiting
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT06661122 2026-05-19
HAYATE
Bayer
Recruiting
NCT07223372 2026-05-18
TARA
Bayer
Recruiting
NCT06255041 2026-05-15
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
Completed
NCT07093801 2026-05-15
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Novartis
Recruiting
NCT07538843 2026-05-15
DARE
Bayer
Not yet recruiting
NCT06011954 2026-05-14
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Astellas Pharma Inc
Recruiting
NCT06334120 2026-05-13
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Bayer
Recruiting
NCT04122976 2026-05-11
DAROL
Bayer
Active not recruiting
NCT05901649 2026-05-08
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
NCT07309445 2026-05-08
Nova-sTAR
Janssen Research & Development, LLC
Recruiting
NCT07451002 2026-05-08
OBSAPA
Janssen Cilag S.A.S.
Recruiting
NCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT07560215 2026-05-01
PROMET-BR
AstraZeneca
Not yet recruiting
NCT03647878 2026-04-30
CABOCARE
Ipsen
Active not recruiting
NCT04106349 2026-04-30
REPLICA
Ipsen
Active not recruiting
NCT04981119 2026-04-30
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
NCT05520099 2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
NCT05981131 2026-04-29
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc.
Active not recruiting
NCT06031805 2026-04-27
PROWESs
AstraZeneca
Recruiting
NCT04943380 2026-04-24
DRIVE
Pacific Edge Limited
Completed
NCT05889195 2026-04-24
microDRIVE
Pacific Edge Limited
Recruiting
NCT05982561 2026-04-23
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Early is Good Inc.
Recruiting
NCT07543757 2026-04-22
PRIME
Sequenom, Inc.
Recruiting
NCT02695121 2026-04-17
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
AstraZeneca
Completed
NCT06010914 2026-04-15
DADOX
Bayer
Active not recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT06517719 2026-04-13
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Novartis
Recruiting
NCT06874114 2026-04-13
RE-ENGAGE
Bayer
Active not recruiting
NCT07406282 2026-04-09
Double-DARE
Bayer
Recruiting
NCT05467176 2026-04-08
OPTYX
Sumitomo Pharma America, Inc.
Active not recruiting
NCT06973161 2026-04-08
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Completed
NCT07514143 2026-04-07
Bladder EpiCheck Product Development Study
Nucleix Ltd.
Recruiting
NCT07344779 2026-04-03
ROAD
Bayer
Active not recruiting
NCT04052048 2026-04-02
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
Immunis.AI
Recruiting
NCT04822350 2026-04-02
AVENANCE
Pfizer
Completed
NCT07144319 2026-04-01
ENAiBLE
Photocure
Recruiting
NCT07290270 2026-03-30
PSMAreal
Novartis
Recruiting
NCT07484269 2026-03-20
PULSE
Novartis
Not yet recruiting
NCT07477756 2026-03-19
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Novartis
Completed
NCT05102110 2026-03-16
ORI-EGI-03
Origin Sciences
Recruiting
NCT07474051 2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
NCT07454603 2026-03-06
PROSTest_STRAT
Wren Laboratories LLC
Not yet recruiting
NCT07455058 2026-03-06
VAPOR-LTR
Francis Medical Inc.
Not yet recruiting
NCT07450157 2026-03-04
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Novartis
Completed
NCT02184416 2026-02-27
ADONIS
Pfizer
Completed
NCT05858749 2026-02-27
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Completed
NCT05968599 2026-02-25
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
Completed
NCT07432360 2026-02-25
Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Virdx, Inc.
Recruiting